Drugs / PlyD1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01444352 | Jun 2010 → Jan 2011 | streptococcal pneumonia | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PlyD1 | “Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults.” PMID 23153437 ↗ Nov 2012 |
| Modality | Protein / enzyme biologic | “single-antigen protein vaccine candidate” PMID 23153437 ↗ Nov 2012 |
| Route | Intramuscular | “0.5 mL, Intramuscular (Low dose)” NCT01444352 ↗ |